Trial is not very expensive as this reads. Doubt they'll do a Cap raise … their emphasis has always been to support shareholder value.
Under the agreement, Race is obliged to provide Bisantrene at no cost to Sheba and the Investigator, and to provide a grant to Sheba of €78,975 to support the trial. Race is also obliged to provide clinical trial insurance, which was arranged by Race prior to signing the agreement.
Ann: Bisantrene AML trial to start in Israel, page-13
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
-0.115(7.03%) |
Mkt cap ! $259.1M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.63 | $1.52 | $167.4K | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2239 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 391 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |